Clinical & Translational Research

Dr. Mittal specializes in the intricate dynamics of host-pathogen interactions, with a particular emphasis on the innate immune response to Mycobacterium tuberculosis (Mtb).

Dr. Mody's overarching research interests are in utilizing implementation science and epidemiologic methods to better understand how to deliver high-quality and patient-centered HIV care in routine practice resource-limited settings.

Dr. Joshua Nordman specializes in clinical infectious diseases, with a particular interest in the intersection of social vulnerability and infection. His research interests include antimicrobial research that leverages electronic health record (EHR) systems and large language models (LLMs) for improvement in patient care outcomes. 

Dr. Olsen’s primary research interests involve the epidemiology of hospital-acquired infections, particularly surgical site infection, and the use of administrative and claims data to study surgical complications.

Areas of Interest in ID:
Host pathogen interaction in bacterial pathogenesis

Dr. Priya Pal is a physician-scientist and infectious disease specialist whose research bridges fundamental immunology and translational HIV science. She additionally runs an HIV cure trial out of the Infectious Diseases Clinical Research Unit (ID-CRU) and serves on the inpatient infectious diseases consult service.

Dr. Pande specializes in the care of transplant recipients, with a special focus on opportunistic infections and antimicrobial prophylaxis in bone marrow transplant recipients.

Dr. Parra-Rodriguez specializes in the longitudinal clinical care of people with HIV, with a special clinical research focus on aging, age-related clinical conditions, and mental health in people with HIV. As a core faculty member of the ID Fellowship Program, he serves as Co-Director of the STI and HIV Track.

Dr. Philips is principal investigator of an NIH-funded lab that studies how Mycobacterium tuberculosis evades the host immune response.

Marilia Pinzone is an infectious diseases physician-scientist. As a scientist, she is currently investigating chronic inflammation during antiretroviral therapy (ART). As a physician, Dr. Pinzone's interests are outpatient care of people living with HIV, infectious diseases, and metabolic complications of HIV.

Dr. Powderly has been actively involved in HIV-related clinical research for over thirty years with specific interests in opportunistic infections, metabolic complications and long-term outcomes of antiretroviral therapy.

Dr. Presti specializes in clinical and translational research in infectious disease, with a special focus on HIV, SARS-CoV-2 and other viral infections.

Dr. Ramakrishnan’s research focuses on applying implementation science strategies to improve domestic HIV prevention and care, particularly for cisgender women.

Dr. Rauseo specializes in clinical infectious diseases, with a special focus on mycology and infectious that affect immunocompromised hosts. Since the outset of the COVID-19 pandemic she has served as an investigator in the Infectious Disease Clinical Research Unit (ID-CRU) in multiple clinical trials and translational research in the fight against COVID-19.

Dr. Reno specializes in sexual health care, with a special focus on the clinical care of sexually transmitted infections (STI) and the intersection with HIV prevention.

Dr. Rosa’s experience in the statistical analysis of complex datasets (utilizing multiple types of evidence spanning treatments or species) has led to the identification differentially expressed genes, drug targets and pathways of interest for experimental verification.

Dr. Sayood performs clinical research with a specific focus on antimicrobial stewardship and clinical decision support. As a core faculty member of the ID Fellowship Training Program, Dr. Sayood is the Director of the Antimicrobial Stewardship Track.

Dr. Sheikh specializes in bacterial pathogenesis, host-pathogen interactions, host responses, and vaccines, with a special focus on enteric bacterial pathogens, including enterotoxigenic E. coli (ETEC) and C. difficile infections.

Dr. Spec's research is in fungal infections, particularly in immunocompromised patients, including those with transplants. His research focuses on Cryptococcus, Histoplasma, Candida, Aspergillus and other invasive molds. Dr. Spec also runs the division’s clinic focusing on invasive fungal infections, where he takes care of both immunocompromised and immunocompetent patients with fungal infections, which he considers the best and most rewarding part of his job.

Dr. Trautner’s research focuses on diagnostic and antibiotic stewardship, particularly for urinary tract infections (UTIs). She has led trials to disseminate successful antibiotic stewardship interventions, improve the diagnosis and treatment of UTIs in men, develop bacteriophage therapy for UTIs in individuals with spinal cord injuries, and to reduce overdiagnosis of catheter-associated UTI.